Psychedelic therapy for body dysmorphic disorder

被引:1
作者
Johnson, Shevaugn [1 ]
Letheby, Chris [2 ,3 ]
机构
[1] Flinders Univ S Australia, Coll Educ Psychol & Social Work, Sturt Rd, Bedford Pk, SA 5042, Australia
[2] Univ Western Australia, Dept Philosophy, 35 Stirling Hwy, Crawley, WA 6009, Australia
[3] Univ Adelaide, Dept Philosophy, North Terrace, Adelaide, SA 5005, Australia
来源
JOURNAL OF PSYCHEDELIC STUDIES | 2022年 / 6卷 / 01期
基金
澳大利亚研究理事会;
关键词
body dysmorphic disorder; classic psychedelic; psilocybin; psychedelic therapy; COGNITIVE-BEHAVIORAL THERAPY; DOUBLE-BLIND; PSILOCYBIN; METAANALYSIS; SEROTONIN; AUGMENTATION; RECOGNITION; EXPERIENCES; PREVALENCE; MODEL;
D O I
10.1556/2054.2022.00200
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this opinion piece we propose the investigation of psychedelic-assisted psychotherapy for the treatment of body dysmorphic disorder (BDD). BDD is a psychiatric disorder characterised by appearance-based preoccupations and accompanying compulsions. While safe and effective treatments for BDD exist, non-response and relapse rates remain high. Therefore, there is a need to investigate promising new treatment options for this highly debilitating condition. Preliminary evidence suggests safety, feasibility, and potential efficacy of psychedelic treatments in disorders that share similar psychopathological mechanisms with BDD. Drawing on this evidence, as well as on relevant qualitative reports and theoretical proposals, we argue that it would be worthwhile to conduct a phase 2a study aimed at assessing the safety and feasibility of psychedelic-assisted psychotherapy in BDD. We also offer some suggestions for how future research ought to proceed.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 83 条
[1]   Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies [J].
Andersen, Kristoffer A. A. ;
Carhart-Harris, Robin ;
Nutt, David J. ;
Erritzoe, David .
ACTA PSYCHIATRICA SCANDINAVICA, 2021, 143 (02) :101-118
[2]   Suicidality in body dysmorphic disorder (BDD): A systematic review with meta-analysis [J].
Angelakis, Ioannis ;
Gooding, Patricia A. ;
Panagioti, Maria .
CLINICAL PSYCHOLOGY REVIEW, 2016, 49 :55-66
[3]  
APA, 1980, Diagnostic and statistical manual of mental disorders
[4]   Emotions and brain function are altered up to one month after a single high dose of psilocybin [J].
Barrett, Frederick S. ;
Doss, Manoj K. ;
Sepeda, Nathan D. ;
Pekar, James J. ;
Griffiths, Roland R. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[5]   Cognitive Behavioral Therapy for Body Image and Self-Care (CBT-BISC) in Sexual Minority Men Living With HIV: A Randomized Controlled Trial [J].
Blashill, Aaron J. ;
Safren, Steven A. ;
Wilhelm, Sabine ;
Jampel, Jonathan ;
Taylor, S. Wade ;
O'Cleirigh, Conall ;
Mayer, Kenneth H. .
HEALTH PSYCHOLOGY, 2017, 36 (10) :937-946
[6]   Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies [J].
Breeksema, Joost J. ;
Niemeijer, Alistair R. ;
Krediet, Erwin ;
Vermetten, Eric ;
Schoevers, Robert A. .
CNS DRUGS, 2020, 34 (09) :925-946
[7]   REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics [J].
Carhart-Harris, R. L. ;
Friston, K. J. .
PHARMACOLOGICAL REVIEWS, 2019, 71 (03) :316-344
[8]   Psilocybin with psychological support for treatment-resistant depression: six-month follow-up [J].
Carhart-Harris, R. L. ;
Bolstridge, M. ;
Day, C. M. J. ;
Rucker, J. ;
Watts, R. ;
Erritzoe, D. E. ;
Kaelen, M. ;
Giribaldi, B. ;
Bloomfield, M. ;
Pilling, S. ;
Rickard, J. A. ;
Forbes, B. ;
Feilding, A. ;
Taylor, D. ;
Curran, H. V. ;
Nutt, D. J. .
PSYCHOPHARMACOLOGY, 2018, 235 (02) :399-408
[9]   Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms [J].
Carhart-Harris, Robin L. ;
Roseman, Leor ;
Bolstridge, Mark ;
Demetriou, Lysia ;
Pannekoek, J. Nienke ;
Wall, Matthew B. ;
Tanner, Mark ;
Kaelen, Mendel ;
McGonigle, John ;
Murphy, Kevin ;
Leech, Robert ;
Curran, H. Valerie ;
Nutt, David J. .
SCIENTIFIC REPORTS, 2017, 7
[10]   Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study [J].
Carhart-Harris, Robin L. ;
Bolstridge, Mark ;
Rucker, James ;
Day, Camilla M. J. ;
Erritzoe, David ;
Kaelen, Mendel ;
Bloomfield, Michael ;
Rickard, James A. ;
Forbes, Ben ;
Feilding, Amanda ;
Taylor, David ;
Pilling, Steve ;
Curran, Valerie H. ;
Nutt, David J. .
LANCET PSYCHIATRY, 2016, 3 (07) :619-627